BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 25789543)

  • 21. Serum-Based Phospho-Neurofilament-Heavy Protein as Theranostic Biomarker in Three Models of Traumatic Brain Injury: An Operation Brain Trauma Therapy Study.
    Yang Z; Zhu T; Mondello S; Akel M; Wong AT; Kothari IM; Lin F; Shear DA; Gilsdorf JS; Leung LY; Bramlett HM; Dixon CE; Dietrich WD; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM; Wang KKW
    J Neurotrauma; 2019 Jan; 36(2):348-359. PubMed ID: 29987972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
    Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
    Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kollidon VA64 Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
    Osier ND; Bramlett HM; Shear DA; Mondello S; Carlson SW; Dietrich WD; Deng-Bryant Y; Wang KKW; Hayes RL; Yang Z; Empey PE; Poloyac SM; Lafrenaye AD; Povlishock JT; Gilsdorf JS; Kochanek PM; Dixon CE
    J Neurotrauma; 2021 Sep; 38(17):2454-2472. PubMed ID: 33843262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
    Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
    Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous Administration of Simvastatin Improves Cognitive Outcome following Severe Traumatic Brain Injury in Rats.
    Mountney A; Boutté AM; Gilsdorf J; Lu XC; Tortella FC; Shear DA
    J Neurotrauma; 2016 Aug; 33(16):1492-500. PubMed ID: 26542887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression levels of ubiquitin C-terminal hydrolase-L1 and serum glial fibrillary acidic protein and its clinical significance in patients with acute cerebral infarction].
    Hu C; Yang X; Mao D; Lou S; Dai Q; Chen J; Cheng X; Wang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):284-290. PubMed ID: 28364101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) biomarkers in predicting CT scan results and neurological outcomes in children with traumatic brain injury (BRAINI-2 paediatric study): protocol of a European prospective multicentre study.
    Lorton F; Lagares A; de la Cruz J; Méjan O; Pavlov V; Sapin V; Poca MA; Lehner M; Biberthaler P; Chauviré-Drouard A; Gras-Le-Guen C; Scherdel P; ;
    BMJ Open; 2024 May; 14(5):e083531. PubMed ID: 38754888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats.
    Glushakova OY; Jeromin A; Martinez J; Johnson D; Denslow N; Streeter J; Hayes RL; Mondello S
    Toxicol Sci; 2012 Nov; 130(1):158-67. PubMed ID: 22790971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy].
    Jiang SH; Wang JX; Zhang YM; Jiang HF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1193-6. PubMed ID: 25523563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Umbilical cord blood concentrations of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in neonates developing hypoxic-ischemic encephalopathy.
    Zaigham M; Lundberg F; Hayes R; Undén J; Olofsson P
    J Matern Fetal Neonatal Med; 2016; 29(11):1822-8. PubMed ID: 26135781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
    Luger S; Jæger HS; Dixon J; Bohmann FO; Schaefer J; Richieri SP; Larsen K; Hov MR; Bache KG; Foerch C;
    Neurocrit Care; 2020 Aug; 33(1):39-48. PubMed ID: 32096121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
    Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
    J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
    Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond.
    Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S
    J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and subacute microRNA dysregulation is associated with cytokine responses in the rodent model of penetrating ballistic-like brain injury.
    Johnson D; Cartagena CM; Tortella FC; Dave JR; Schmid KE; Boutté AM
    J Trauma Acute Care Surg; 2017 Jul; 83(1 Suppl 1):S145-S149. PubMed ID: 28452880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.